RSS
|
Markets spent the week balancing record private-market exuberance against mounting macro and concentration risk. This edition leads with five Opalesque Exclusives, then synthesises the week's industry flow across performance, capital, launches, macro, AI, regulation and digital assets.
EXCLUSIVE
SuperReturn: The Go-To Managers - AVANT BIO At SuperReturn International in Berlin, AVANT BIO founding general partner Daniella Kranjac told Opalesque she invests in the invisible layer of biotech, the picks and shovels of life sciences, deliberately avoiding binary therapeutic risk. She also set out where AI is still missing in pharma and what it takes to survive the conference circuit.
EXCLUSIVE
UBS: Hormuz shock tilts the world UBS argues the disruption at the Strait of Hormuz is tilting the world toward a more fragmented, higher-cost order. Its scenario work suggests Europe would bear the brunt of an oil shock through its energy import dependence, while the US impact would be more contained and a prolonged disruption could materially reset inflation and growth expectations.
EXCLUSIVE
Family offices pivot to resilience and diversification The UBS Global Family Office Report 2026, covering 307 family offices with an average net worth of USD 2.7 billion across more than 30 markets, finds allocators recalibrating toward resilience and diversification rather than abandoning long-held convictions. Geopolitical conflict ranks a...................... To view our full article Click here |
Alternative Market Briefing Weekly
Saturday, June 13, 2026
|
|
|
